首页> 外文期刊>Journal of human hypertension >The evidence for treating hypertension in older people with dementia: a systematic review.
【24h】

The evidence for treating hypertension in older people with dementia: a systematic review.

机译:治疗老年痴呆症高血压的证据:系统评价。

获取原文
获取原文并翻译 | 示例
           

摘要

Hypertension and dementia commonly co-exist in older people, yet guidance is lacking on how to manage these co-existing conditions. The aim of this systematic review was to assess the evidence for the treatment of hypertension in older people with dementia. Medline, EMBASE, Cochrane Library and the national research register archives were searched. Inclusion criteria were: randomised controlled trial of hypertension treatment, included participants aged 65+ years, participants had a diagnosis of dementia (global cognitive decline for at least 6 months affecting daily function), and the study assessed cognitive outcomes using validated tools. Dementia prevention studies and poor quality studies were excluded. The initial search revealed 1178 papers of potential interest, of which 24 were selected for review and six met the full inclusion criteria. Trials included people with mild-to-moderate but not severe dementia; exclusion criteria for the trials were extensive. Four trials were placebo-controlled RCTs; the remaining two compared different antihypertensives. All trials reported MMSE scores at baseline and follow-up; four reported blood pressure changes at follow-up; and only three reported cardiovascular morbidity or mortality at follow-up. Only one of four placebo-controlled studies showed evidence of blood pressure reduction, but no clear evidence for benefit (or harm) from antihypertensives on cognition, physical function or other cardiovascular outcomes. We found no evidence to confirm or refute the hypothesis that treatment of hypertension in people with dementia leads to overall health benefit.
机译:高血压和痴呆症通常在老年人中共存,但缺乏如何管理这些并存疾病的指导。这项系统评价的目的是评估老年痴呆症患者高血压治疗的证据。搜索了Medline,EMBASE,Cochrane图书馆和国家研究注册档案。纳入标准为:高血压治疗的随机对照试验,包括65岁以上的参与者,参与者患有痴呆症的诊断(至少6个月的整体认知能力下降影响日常功能),并且该研究使用经过验证的工具评估了认知结果。痴呆症预防研究和不良质量研究被排除在外。初步搜索显示1178篇潜在兴趣论文,其中24篇被选中进行审查,其中6篇符合完全纳入标准。试验包括轻度至中度但不严重的痴呆症患者;试验的排除标准是广泛的。有四项试验是安慰剂对照的RCT。其余两个比较了不同的降压药。所有试验均在基线和随访中报告了MMSE评分;在随访中报告了四次血压变化;仅有3例在随访中报告了心血管疾病的发病率或死亡率。在四项安慰剂对照研究中,只有一项显示出血压降低的证据,但没有明确的证据表明降压药对认知,身体功能或其他心血管疾病的益处(或危害)。我们没有证据证实或驳斥痴呆症患者的高血压治疗可带来整体健康益处的假设。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号